FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
114,331,829
Total 13F shares
94,438,853
Share change
+722,122
Total reported value
$8,194,463,579
Put/Call ratio
170%
Price per share
$86.79
Number of holders
264
Value change
+$63,508,082
Number of buys
146
Number of sells
106

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2021

As of 30 Jun 2021, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 264 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 94,438,853 shares. The largest 10 holders included Redmile Group, LLC, VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock Inc., FMR LLC, Casdin Capital, LLC, Johnson & Johnson Innovation - JJDC, Inc., PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, and STATE STREET CORP. This page lists 264 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.